Personalized targeted glioblastoma therapies by ex vivo drug screening : Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT)
Recent Publication
The ATTRACT study is an innovative research project that offers new hope for people with an aggressive brain tumour, glioblastoma. Instead of relying solely on standard therapies, patients' tumour cells are specifically tested for various drugs in the laboratory in order to find an individual treatment recommendation. The aim is to significantly extend the survival time of patients. The Division of Neurology at St. Pölten University Hospital is involved in this important, internationally registered study.
ATTRACT study group , & Oberndorfer, S. (2025). Personalized targeted glioblastoma therapies by ex vivo drug screening: Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT). Neuro-Oncology Advances, 7(1), vdaf056. Article vdaf056. https://doi.org/10.1093/noajnl/vdaf056
Prim. Univ.-Prof. PD Dr. Stefan Oberndorfer FEAN
Division of Neurology (University Hospital St. Pölten)